AusCann Group Holdings (ASX:AC8) Presentation, FNN Investor Event, September 2018, Sydney

Company Presentations

AusCann Group Holdings (ASX:AC8) Managing Director, Elaine Darby presents its final dose cannabinoid capsule study, 2018 crop yields, production and outlook at FNN's Investor Event.

Key points:

- Delivering high quality, cost effective cannabinoid medicines to patients
- Pharmaceutical products for the management of chronic pain
- Regulatory update - two key Federal Government changes
- Processes to provide patients with access
- Opening up of export opportunity
- Joint venture based in Chile between AC8 and Fundación Daya

For more information, watch Managing Director Elaine Darby present. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.